Drugmakers File 2nd Suit To Thwart Generic Xyzal
Belgian drugmaker UCB SA and its U.S. partner, Sepracor Inc., have filed their second lawsuit in two months in an effort to stave off a generic challenge to their antihistamine drug...To view the full article, register now.
Already a subscriber? Click here to view full article